# Boston Scientific to acquire Claret Medical for up to $270 million

Boston Scientific signed an agreement to acquire Claret Medical, developer of the Sentinel Cerebral Embolic Protection System for TAVR procedures. The transaction includes $220 million in up-front cash and up to $50 million in milestone payments.

- Type: Acquisition
- Announced: 2018-07-20
- Where: United States
- Value: $270.0M
- Status: announced
- Products: Sentinel Cerebral Embolic Protection System
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Boston Scientific](https://endata.com/companies/15966.md) (acquirer)
- [Claret Medical](https://endata.com/companies/33248.md) (target)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/boston-scientific-announces-agreement-to-acquire-claret-medical-inc-300684162.html), 2018-07-20: "This acquisition will expand our commercial portfolio to include an important adjunctive offering aimed at improving TAVR patient outcomes."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.